Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Skandia beats forecasts, but U.S. sales lag

Article Abstract:

Skandia AB posted higher-than-expected earnings for the 2001 second-quarter. The company posted 1.68 billion kronor (183.7 million euros) in operating profits for the period, compared to 1.5 billion kronor in the same 2000 period.

Author: Grotte, Gabriella
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Skandia posts 3rd-quarter loss citing weak global markets

Article Abstract:

Foersaekrings AB Skandia posted a 4.39 billion Swedish kronor loss for the 2001 third-quarter. The company posted a 1.72 billion kroner profit during the same 2000 period.

Author: Bergstrom, Rupini
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Finance, Insurance industry, Insurance, Sweden, Skandia AB
Similar abstracts:
  • Abstracts: Generali's net profit rises sharply. Skandia's profit rises, but investors remain wary. Aetna's net profit dropped sharply in second quarter
  • Abstracts: Warning call: as industry pushes headsets in cars, U.S. agency sees danger. Volvo takes a net gamble
  • Abstracts: Al Gore's investor problem. America's focus group
  • Abstracts: Earnings increased in third quarter at drug companies. Galen's profit rose 75% in quarter on U.S. sales
  • Abstracts: Lucent to restructure as revenue drops 28%. Clash forces out Lucent's Hopkins. Lucent dismisses embattled McGinn
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.